Travere Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name's Anupam Rama. I am one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Priyanka Grover, Joyce Zhou, and Rati Pinhe.
Our next presenting company is Travere, and presenting on behalf of the company, we have CEO, Eric Dube.
Good afternoon, everyone, and thank you to JP Morgan, Anupam, and team. My name is Eric Dube. I'm the President and CEO of Travere Therapeutics. It's my pleasure to be here and I appreciate your time learning a bit more about the work that we're doing at Travere.
You can see here our forward-looking statements, which you can find this and other details on our website.
For us at Travere, being a rare disease is a deep commitment, and for so many of us, is personal. There are so many of my colleagues who joined Travere because they themselves have a personal connection to rare disease,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investorsā 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
